Infanrix
® (
DTaP) is a childhood vaccine that offers protection against diphtheria, tetanus, and pertussis (
whooping cough), serious conditions that are caused by bacteria. The various components of this vaccine work by "tricking" the body into thinking it has been exposed to these different infections. The body produces antibodies that will help fight the infections if future exposure occurs.
The Infanrix vaccine is given in a series of five injections. The first dose is typically given at two months of age, and the fifth dose is given between four and six years of age. Infanrix is injected into a muscle (intramuscularly), usually in the thigh for infants; in older children, the upper arm can be used.
While most children tolerate Infanrix well, side effects are possible. Some of the common problems that have been reported with this vaccine include drowsiness, loss of appetite, and skin reactions at the injection site.
(For more information about this vaccine, click Infanrix. This article covers topics such as dosing guidelines, available forms, warnings, and other potential side effects.)
